Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Linsidomine hydrochloride

Linsidomine hydrochloride
Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.
Catalog No. T23356Cas No. 16142-27-1
Select Batch
Purity:99.81%
Contact us for more batch information
Resource Download

Linsidomine hydrochloride

Catalog No. T23356Cas No. 16142-27-1
Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
5 mg$64In Stock
10 mg$97In Stock
25 mg$176In Stock
50 mgInquiryIn Stock
1 mL x 10 mM (in DMSO)$64In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Linsidomine hydrochloride"

Product Introduction

Bioactivity
Description
Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.
In vitro
SIN-1 decreases myocardial necrosis and reperfusion-induced endothelial dysfunction in models of myocardial ischemia-reperfusion [1][2].
In vivo
SIN-1 (chloride) is the active metabolite of molsidomine. SIN-1 (chloride) exhibits a potent vasorelaxant effect and inhibition of platelet aggregation.[1]
SIN-1 (chloride) decreases myocardial necrosis and reperfusion-induced endothelial dysfunction in models of myocardial ischemia-reperfusion.[2]
AliasSIN-1 chloride
Chemical Properties
Molecular Weight206.63
FormulaC6H11ClN4O2
Cas No.16142-27-1
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 22.5 mg/mL (108.9 mM), Sonication and heating to 60℃ are recommended.
H2O: 45.0 mg/mL (217.8 mM), Sonication is recommended.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM4.8396 mL24.1978 mL48.3957 mL241.9784 mL
5 mM0.9679 mL4.8396 mL9.6791 mL48.3957 mL
10 mM0.4840 mL2.4198 mL4.8396 mL24.1978 mL
20 mM0.2420 mL1.2099 mL2.4198 mL12.0989 mL
50 mM0.0968 mL0.4840 mL0.9679 mL4.8396 mL
100 mM0.0484 mL0.2420 mL0.4840 mL2.4198 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Linsidomine hydrochloride | purchase Linsidomine hydrochloride | Linsidomine hydrochloride cost | order Linsidomine hydrochloride | Linsidomine hydrochloride chemical structure | Linsidomine hydrochloride in vivo | Linsidomine hydrochloride in vitro | Linsidomine hydrochloride formula | Linsidomine hydrochloride molecular weight